Three things to know:
1. Mr. Loerop will supervise Anika’s global business development including management of new business opportunities, initiatives, mergers, acquisitions, partnerships and licensing agreements.
2. He has over 30 years of experience in business and corporate development in the biopharma sector.
3. Mr. Loerop served in leadership roles at Lupin Pharmaceuticals, Alexion Pharmaceuticals, GlaxoSmithKline and Steifel Laboratories.
“Jim’s depth of knowledge and experience will be instrumental to the refinement and execution of our long-term growth strategy, which will include identifying partnership opportunities to expand our commercial portfolio and global footprint,” said Joseph Darling, President and CEO of Anika.
More articles on devices:
Cerapedics expands Colorado HQ — 3 things to know
HSS acquires low-dose orthopedic imaging system — 3 insights
Medtronic secures market-leading position through Titan Spine acquisition, analyst says
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.